Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

People who get health insurance through the Affordable Care Act could soon see their monthly premiums sharply increase as ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Rosie Green gets the lowdown on the common causes - and the best treatments - from leading dermatologist Dr Stefanie Williams.

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

IN 1971 RICHARD NIXON, then America’s president, announced a “war on cancer”. Just two years earlier the Apollo programme had ...

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...